SCHEMBL1015300

SCHEMBL1015300

COC(=O)c1cc(Cl)ccc1NC(=O)CSCC(=O)Nc1cccc(-c2ccc(F)cc2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.59
CNR1 P21554 2/20 0.50
KDM4E B2RXH2 1/20 0.46
MGLL Q99685 1/20 0.44
MEN1 O00255 4/20 0.44
KMT2A Q03164 4/20 0.44
LMNA P02545 3/20 0.44
MAPT P10636 3/20 0.44
GAA P10253 2/20 0.44
HPGD P15428 1/20 0.44
SERPINE1 P05121 1/20 0.43
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
RAB9A P51151 1/20 0.41
PRMT5 O14744 1/20 0.41
WDR77 Q9BQA1 1/20 0.41
GRIK1 P39086 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
F10 P00742 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1015837 0.89 CNR1 (0.51) ALDH1A1CNR1KDM4EMGLLMEN1
SCHEMBL1019407 0.89 SERPINE1 (0.54) ALDH1A1CNR1MGLLMEN1KMT2A
SCHEMBL1016354 0.89 CNR1 (0.50) ALDH1A1CNR1KDM4EMEN1KMT2A
SCHEMBL1015739 0.88 SERPINE1 (0.53) ALDH1A1CNR1MGLLMEN1KMT2A
SCHEMBL1015741 0.87 CNR1 (0.51) ALDH1A1CNR1MGLLMEN1KMT2A
SCHEMBL1012933 0.86 SERPINE1 (0.61) ALDH1A1CNR1KDM4EMEN1KMT2A
SCHEMBL1015454 0.80 ALDH1A1 (0.51) ALDH1A1KDM4EMEN1KMT2ALMNA
SCHEMBL1015100 0.79 SERPINE1 (0.55) CNR1KDM4EMGLLMAPTGAA
SCHEMBL1014811 0.79 ALDH1A1 (0.45) ALDH1A1KDM4EMEN1KMT2ALMNA
SCHEMBL1015946 0.78 SERPINE1 (0.54) CNR1KDM4EMGLLMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ALDH1A1 888/4885CNR1 3950/4885KDM4E 4108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.